VRCA Historical PE Ratio image   This VRCA PE ratio history page last updated 11/8/2022
VRCA Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2022
11/7/2022
2.380.070.288.5
Q2 2022
8/11/2022
3.63-0.37-1.48NA
Q1 2022
5/9/2022
6.08-0.25-1.00NA
Q4 2021
3/2/2022
8.59-0.35-1.40NA
Q3 2021
11/12/2021
12.33-0.47-1.88NA
Q2 2021
8/10/2021
11.33-0.43-1.72NA
Q1 2021
5/7/2021
11.50-0.04-0.16NA
Q4 2020
3/4/2021
13.34-0.52-2.08NA
Q3 2020
11/9/2020
7.84-0.42-1.68NA
Q2 2020
8/5/2020
6.72-0.38-1.52NA
Q1 2020
5/7/2020
10.46-0.39-1.56NA
Q4 2019
3/13/2020
9.11-0.31-1.24NA
Q3 2019
11/6/2019
14.22-0.24-0.96NA
Q2 2019
8/7/2019
10.93-0.28-1.12NA
Q1 2019
5/7/2019
9.05-0.30-1.20NA
Q4 2018
3/7/2019
11.76-0.30-1.20NA
Q3 2018
11/7/2018
13.34-0.27-1.08NA
VRCA PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2022
11/7/2022
2.380.07-0.90NA
Q2 2022
8/11/2022
3.63-0.37-1.44NA
Q1 2022
5/9/2022
6.08-0.25-1.50NA
Q4 2021
3/2/2022
8.59-0.35-1.29NA
Q3 2021
11/12/2021
12.33-0.47-1.46NA
Q2 2021
8/10/2021
11.33-0.43-1.41NA
Q1 2021
5/7/2021
11.50-0.04-1.36NA
Q4 2020
3/4/2021
13.34-0.52-1.71NA
Q3 2020
11/9/2020
7.84-0.42-1.50NA
Q2 2020
8/5/2020
6.72-0.38-1.32NA
Q1 2020
5/7/2020
10.46-0.39-1.22NA
Q4 2019
3/13/2020
9.11-0.31-1.13NA
Q3 2019
11/6/2019
14.22-0.24-1.12NA
Q2 2019
8/7/2019
10.93-0.28-1.15NA
Q1 2019
5/7/2019
9.05-0.30NANA
Q4 2018
3/7/2019
11.76-0.30NANA
Q3 2018
11/7/2018
13.34-0.27NANA
Quotes delayed 20 minutes

Email EnvelopeFree VRCA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Verrica Pharmaceuticals (VRCA) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

VRDN PE Ratio History
VRPX PE Ratio History
VRTX PE Ratio History
VSTM PE Ratio History
VTGN PE Ratio History
VTRS PE Ratio History
VTVT PE Ratio History
VVOS PE Ratio History
VXRT PE Ratio History
VYGR PE Ratio History
How should the VRCA historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Verrica Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this VRCA Historical PE Ratio page.

What is the average historical PE for VRCA based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The VRCA historical PE ratio using the annualized quarterly earnings method works out to 8.5.

What is the average historical PE for VRCA based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The VRCA historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the VRCA Historical PE Ratio information for Verrica Pharmaceuticals' stock. The average VRCA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 8.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average VRCA historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this VRCA historical PE result, against the recent PE: when this page was posted on 11/7/2022, the most recent closing price for VRCA had been 2.38, and the most recent quarterly earnings result, annualized, was 0.28. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent VRCA PE on 11/7/2022 based on annualized quarterly EPS was 8.5.

For self directed investors doing their due diligence on VRCA or any other given stock, valuation analysis for VRCA can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Verrica Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for VRCA. Thanks for visiting, and the next time you need to research VRCA Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Funds Holding RTI, LLEN Options Chain, BSQR Average Annual Return.

 

VRCA Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.